NDPAC Annual Convention

12:00PM-2:00PM EST

LEONARD RAPPA, PHARMD, PROFESSOR, PSYCHIATRIC PHARMACY PRACTICE, TENURED
FLORIDA A&M UNIVERSITY
COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES, INSTITUTE OF PUBLIC HEALTH (COPPS, IPH)
SOUTH FLORIDA PHARMACY PRACTICE CENTER, FT. LAUDERDALE, FLORIDA

Upon completion of this activity, pharmacists will be able to: Define what makes a drug a psychedelic; Differentiate between a drug that is psychoanaleptic or psychomimetic; Identify substances that are psychoanaleptic or psychomimetic; Compare prescription psychotropics to over-the-counter, herbal, and illicit drugs for safety and efficacy; Describe the mechanism of action psychedelics; Recognize the common side effects of current psychoactive substances. Upon completion of this activity, pharmacists will be able to: Describe the schedules of controlled substances according to their class or purpose; 1.Identify drugs considered not to be based on a legitimate medical purpose; Define cannabis and CBD, THC, Hemp, Cannabinoid, Medical v. Recreational Marijuana; Discuss the legislative acts regarding cannabis – state what “cannabis” products are “legal” and which are not; Examine federal versus state laws on cannabis; Debate & Discuss the potential direction of pharmacy practice with the introduction of cannabis; Compare and contrast federal v. state laws on prescribing, recommending and dispensing controlled substances; Discuss & Debate drug-free workplace in the era of medical and recreational use marijuana as a policy paradigm; List counseling duties for patients with opioid prescriptions; List counseling obligation for patients taking prescription medications and cannabis; Identify the pharmacy staff’s role in HIPAA compliance.

UAN: 0011-9999-25-008-L01-P
2.0 HOURS GCE

Back to top

4:30PM-6:30-PM EST

SALESIA SMITH-GORDON, B.S. PHARM., JD.
FOUNDER & MANAGING ATTORNEY
LAW OFFICE OF SALESIA V. SMITH-GORDON, PA, WEST PALM BEACH, FL.

Upon completion of this activity, pharmacists will be able to: Describe the schedules of controlled substances according to their class or purpose; 1.Identify drugs considered not to be based on a legitimate medical purpose; Define cannabis and CBD, THC, Hemp, Cannabinoid, Medical v. Recreational Marijuana; Discuss the legislative acts regarding cannabis – state what “cannabis” products are “legal” and which are not; Examine federal versus state laws on cannabis; Debate & Discuss the potential direction of pharmacy practice with the introduction of cannabis; Compare and contrast federal v. state laws on prescribing, recommending and dispensing controlled substances; Discuss & Debate drug-free workplace in the era of medical and recreational use marijuana as a policy paradigm; List counseling duties for patients with opioid prescriptions; List counseling obligation for patients taking prescription medications and cannabis; Identify the pharmacy staff’s role in HIPAA compliance.

UAN: 0011-9999-25-011-L03-P
2.0 HOURS GCE

Back to top

2:15PM-4:15 P.M. EST

DAVID DO, PHARM.D.
PGY-1 MANAGED CARE RESIDENT
CARESOURCE – DAYTON, OH

Upon completion of this activity, pharmacists will be able to: Assess the role of vitamins in disease prevention and management, including common deficiencies and toxicities; Evaluate the clinical evidence behind vitamin supplementation and its impact on patient outcomes; Identify patient populations at high risk for vitamin deficiencies and recommend appropriate supplementation needs.

UAN: 0011-9999-25-010-L01-P
2.0 HOURS GCE

Back to top

2:00 PM-4:00 PM EST

AUDREY BOLLER JOHNSON, RPH, CPH, MSM
RXVIEW, LLC, TALLAHASSEE, FL

Upon completion of this activity, pharmacists will be able to: Briefly define Artificial Intelligence (AI) and formulations of significance; Explain how data is used to build Artificial Intelligence (AI) to design predictive medicine capabilities for drug therapy ;Discuss Artificial Intelligence (AI) 's role in predicting drug interactions and optimizing Medication Therapy Management, Comprehensive Patient Care plans, and providing Patient Counseling ;List various Pharmacy Operations workflow utilizing Artificial Intelligence; Discuss the regulatory landscape and the need for guidelines to ensure safe and effective Artificial Intelligence (AI) implementation; Discuss emerging trends and future directions in Artificial Intelligence (AI) technology for pharmacy practice.

0011-9999-25-009-L04-P
2.0 HOURS GCE

Back to top